Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
PaperCitations, authors & open-access status
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 285 citations, 2020 year and bronze oa status.
285
Citations
2020
Year
bronze
OA Status